Next-Generation Blood Test Improves Detection Of Aggressive Prostate Cancer

A next-generation blood test could improve early detection of the most dangerous forms of prostate cancer.

"The major challenge in prostate cancer screening is not just to find more cancer cases, but to identify the cancers that are truly dangerous," said first author Thorgerdur Palsdottir, a researcher at the Karolinska Institute in Stock...

Most Patients Want Docs To Break Cancer News Directly, Not Through Portal Messaging

People are becoming more comfortable communicating with their doctor through clinics’ patient portals.

Folks use the portals to ask their doc questions and even to review the results of recent medical tests.

But there are some matters that still require a face-to-face interaction between doctor and patient, a new study says.

Statins Rarely Cause Severe Muscle Problems, Researchers Say

Concerns about statins causing severe muscle problems are overblown, a new study says.

The cholesterol-lowering drugs can be expected to rarely cause any serious muscle problems, researchers reported June 25 in The Lancet Digital Health.

More than 98% of people eligible for statins are at low risk of serious muscle problems,...

Younger U.S. Generations Increasingly Fear Adulthood, Study Says

Younger U.S. generations appear to be adopting Peter Pan’s fear of growing up, a new study says

Millennial college students (born between 1981 and 1996) feared adulthood more than earlier generations, wishing they could return to the security and happiness of childhood, according to the study.

However, they wound up embracing a...

GLP-1 Weight-Loss Boom Linked To Surge In Poison Control Calls

As the use of GLP-1 medications for weight loss surges, so do calls to U.S. poison control centers, according to a new study.

A team led by Jordan Miller of the University of Texas at San Antonio analyzed reports submitted to the National Poison Data System involving GLP-1 drugs before and after the 2021 approval of semaglutide for the tre...

Very Few Men Discuss Prostate Cancer Screening With Their Doctor

THURSDAY, June 25, 2026 (HealthDay News) — Very few middle-aged men are discussing prostate cancer screening with their doctor, even though they face a decision whether or not to be tested, a new study says.

Only about 6% of men have had a documented discussion with their primary care doctor about prostate cancer screening, even...